Key facts
as of Oct 2026- Developer of ophthalmic technologies designed to improve the clinical ophthalmology practice and make patients' lives easy.
- 2EyesVision is valued at approximately $17.1M as of Oct 2026 (last reported valuation).
- It has raised $11.4M; the latest was Equity Crowdfunding ($900K) in Oct 2025.
- Notable investors include INNVIERTE SICC, NextCorps Luminate, Bullnet Capital, EIT Health, Jan Bonel — 6 tracked in total.
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$17.1M
2EyesVision's last reported valuation, Oct 2025. Nothing priced has surfaced since.
Free account
More of 2EyesVision with a free account
- ·Watch 2EyesVision: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for 2EyesVision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About 2EyesVision
Developer of ophthalmic technologies designed to improve the clinical ophthalmology practice and make patients' lives easy. The company commercializes a visual simulator of presbyopic corrections for patients seeking refractive or cataract surgery to experience the real world before undergoing surgery, enabling opticians to recommend a noninvasive, personalized assessment before treatment.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2015
- Employees
- 14
- Website
- 2eyesvision.com/
- Ownership
- Privately Held (backing)